Treating worms during pregnancy might not be associated with wider health benefits for infants in developing countries and policy recommendations should be reviewed

December 20, 2010

Contrary to the expected benefits of routine treatment of worms (helminths) during pregnancy, a single-dose of this widely used intervention is not associated with improved infant survival, or with any effect on the occurrence of infectious diseases, or on growth and anaemia at 1 year of age. These findings, published Online First in The Lancet, contrast with the strongly advocated WHO policy of routine antenatal deworming in developing countries to combat the expected negative effects of worms in pregnancy on maternal health, birth outcomes, and subsequent child health, and suggest that the value of this intervention should be re-examined.

There is evidence that maternal exposure to parasitic worm infections might reduce an infant's immune responses to vaccination and increase susceptibility to other diseases. This is a major concern in developing countries where parasitic worms are endemic and could explain why vaccines appear to be less effective in these countries. Because vaccination is the most cost-effective means of reducing child mortality in developing countries, any intervention that may improve vaccine efficacy should be considered. But the benefits of deworming during pregnancy for this purpose have not been fully assessed.

In this study, Emily Webb from the London School of Hygiene and Tropical Medicine, London, UK, and Ugandan colleagues examined the effects of deworming during pregnancy on immune responses to vaccination and infectious disease incidence in infants.

2507 women in the second or third trimester of pregnancy who were due to deliver in Entebbe General Hospital in Uganda were recruited between April 2003 and November 2005. At enrolment, 1693 women were infected with at least one worm species.

To compare the effects of deworming treatment with no treatment, women were randomly assigned to either one-dose of albendazole plus praziquantel (628 women), albendazole and a praziquantel-matching placebo (625), praziquantel and an albendazole-matching placebo (626), or an albendazole-matching placebo plus a praziquantel-matching placebo (628).

Newborns were followed up until age 12 months to assess immune response to BCG, tetanus, and measles after immunisation at birth, and incidence of infectious diseases (malaria, diarrhoea, pneumonia, measles, and tuberculosis) and vertical HIV transmission.

Findings showed similar infant immune response to BCG, tetanus, and measles immunisation regardless of maternal treatment, and no effect was recorded for either anti-worming treatment on the incidence of infectious diseases during the first year of life or on vertical HIV transmission.

The authors say: "Our findings suggest that one effective anthelmintic intervention given in the second or third trimester of pregnancy is insufficient to alter any effect of maternal worms on vaccine and infectious disease outcomes in infancy."

They conclude: "These results contrast with the expected benefits of routine anthelmintic treatment recently advocated, and the value of such a policy should be reviewed."

In a Comment, Maria Yazdanbakhsh and Adrian Luty from Leiden University Medical Center, Leiden, The Netherlands, say:"This trial seems to resolve speculation about whether helminth infections in the second and third trimester of pregnancy could affect immune responses of newborns to vaccines, and are thereby associated with detrimental health indicators. This finding has serious implications for policy makers who advocate the use of anthelmintic treatment during pregnancy."
Professor Alison Elliott, MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda, and London School of Hygiene and Tropical Medicine, London, UK. E)

Professor Maria Yazdanbakhsh, Leiden University Medical Center, Leiden, The Netherlands. T) +31 (0)71 526 5067 E)

For full Article and Comment, see:



Related Pregnancy Articles from Brightsurf:

COVID-19 has a prolonged effect for many during pregnancy
Symptoms for pregnant women with COVID-19 can be prolonged, lasting two months or longer for a quarter of the women who participated in a national study led by UC San Francisco and UCLA.

Relaxed through pregnancy
A group of researchers from Charité - Universitätsmedizin Berlin have been able to show that maternal psychological wellbeing during pregnancy has a positive effect on newborn infants.

Trajectories of antidepressant medication use during pregnancy
In an analysis of women who started pregnancy when taking antidepressant medications, investigators identified three trajectories of antidepressant dispensing during pregnancy: more than half stopped their treatment, a quarter maintained their treatment throughout pregnancy, and one-fifth discontinued it for a minimum of three months and then resumed it during the postpartum period.

Are women using e-cigarettes during preconception and/or pregnancy?
A new study of 1,365 racially/ethnically diverse, low-income pregnant women found that 4% reported e-cigarette use.

A better pregnancy test for whales
To determine whale pregnancy, researchers have relied on visual cues or hormone tests of blubber collected via darts, but the results were often inconclusive.

Cannabis use during pregnancy
The large health care system Kaiser Permanente Northern California provides universal screening for prenatal cannabis use in women during pregnancy by self-report and urine toxicology testing.

Questions and answers about cannabis use during pregnancy
A new study shows that women have many medical questions about the use of cannabis both before and during pregnancy, and during the postpartum period while breastfeeding.

The effect of taking antidepressants during pregnancy
Exposure to antidepressants during pregnancy and the first weeks of life can alter sensory processing well into adulthood, according to research in mice recently published in eNeuro.

Is ivermectin safe during pregnancy?
Is it safe to give ivermectin to pregnant women? To answer this question, researchers from the Barcelona Institute for Global Health (ISGlobal), an institution supported by 'la Caixa,' conducted a systematic review and meta-analysis of studies that reported cases of accidental exposure to the drug among pregnant women.

Going to sleep on your back in late pregnancy
This study looked at whether going to sleep on your back in the third trimester of pregnancy was associated with average lower birth weights.

Read More: Pregnancy News and Pregnancy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to